Focus Partners Wealth’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-5,500
Closed -$977K – 1900
2024
Q4
$977K Hold
5,500
– – ﹤0.01% 1067
2024
Q3
$1.09M Buy
+5,500
New +$1.03M ﹤0.01% 923

Other funds holding ABBV

Focus Partners Wealth's ABBV Position: Q3 2026 in Review

Focus Partners Wealth increased its AbbVie (ABBV) stake by 2.9% in Q3 2026, buying an estimated $6.95M and bringing the position to 956,660 shares worth $250M. The position accounts for 0.26% of the portfolio, ranked #78.

Focus Partners Wealth first reported a position in ABBV in Q4 2023 and has held it in 12 quarters since. 4,281 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Focus Partners Wealth held 956,660 shares of AbbVie worth $250M as of Q3 2026.
  • Focus Partners Wealth bought 27,094 AbbVie shares in Q3 2026, an estimated $6.95M.
  • AbbVie made up 0.26% of Focus Partners Wealth's portfolio in Q3 2026, its #78 holding.
  • Focus Partners Wealth first reported a position in AbbVie in Q4 2023 and has held it in 12 quarters since.
  • 4,281 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Focus Partners Wealth's 13F filing for Q3 2026, filed 12 Nov 2026.